Chuncheon-si, Gangwon-do, South Korea • 9 Employees
Research
Clinical-stage Biopharmaceutical Company developing hzVSF against COVID-19, Chronic hepatitis B and Influenza. We're also developing and selling rapid diagnostic kits (POCT) for acute infections.